P/E ratio for Hims & Hers Health (HIMS)
P/E ratio as of June 2024 (TTM): -92.6
According to Hims & Hers Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -92.5909. At the end of 2022 the company had a P/E ratio of -20.0.
P/E ratio history for Hims & Hers Health from 2020 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -20.0 | 89.61% |
| 2021 | -10.6 | -68.89% |
| 2020 | -34.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -0.4746 | -99.49% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -2.69 | -97.09% | 🇬🇧 UK |
 Novavax NVAX | -2.12 | -97.71% | 🇺🇸 USA |
 Novocure
NVCR | -12.0 | -87.07% | Jersey |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.